We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

497% more call options, than puts

Call options by funds: $48M | Put options by funds: $8.03M

Holders
616
Holders Change
+616
Holders Change %
–
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.16%
New
616
Increased
–
Reduced
–
Closed
–
Calls
$48M
Puts
$8.03M
Net Calls
+$39.9M
Net Calls Change
+$39.9M

Top Buyers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
+$130M
2
PCM
Pentwater Capital Management
Florida
+$92.5M
3
FCM
Farallon Capital Management
California
+$79M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$67.6M
5
ACM
Abrams Capital Management
Massachusetts
+$60.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
601
Cordant Inc
Oregon
– +$205 +79 New
TFS
602
TrustCore Financial Services
Tennessee
– +$205 +79 New
MF
603
Manchester Financial
California
– +$208 +80 New
PFSC
604
Peoples Financial Services Corp
Pennsylvania
– +$208 +80 New
Kayne Anderson Rudnick Investment Management
605
Kayne Anderson Rudnick Investment Management
California
– +$226 +87 New
CWM
606
Cranbrook Wealth Management
Michigan
– +$239 +92 New
HWM
607
Howard Wealth Management
Connecticut
– +$239 +92 New
MA
608
MCF Advisors
Kentucky
– +$260 +100 New
MSFP
609
Mark Sheptoff Financial Planning
Connecticut
– +$283 +109 New
TWA
610
TCI Wealth Advisors
Arizona
– +$322 +124 New
FMP
611
Financial Management Professionals
Texas
– +$330 +127 New
ST
612
Smithfield Trust
Pennsylvania
– +$343 +132 New
KPW
613
Kore Private Wealth
New York
– +$429 +165 New
FHA
614
First Horizon Advisors
Tennessee
– +$502 +193 New
PCG
615
Private Capital Group
Connecticut
– +$569 +219 New
NIPH
616
NN Investment Partners Holdings
Netherlands
– +$52.9K +20,348 New
Qube Research & Technologies (QRT)
617
Qube Research & Technologies (QRT)
United Kingdom
– +$584K +224,707 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
618
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– +$1.05M +403,598 New
21 22 23 24
25

BMY.RT Hedge Fund Activity: Q4 2019 in Review

616 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q4 2019, worth a combined $1.57B.

Buyers outnumbered sellers: 616 funds opened new BMY.RT positions and 0 closed out — a net gain of 616 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $130M.

  • 616 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $1.57B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q4 2019.
  • 616 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q4 2019 and 0 closed out, a net change of +616 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q4 2019 was Laurion Capital Management, an estimated $130M added.

Based on aggregated 13F filings for Q4 2019.